Scherpereel, A., Baas, P., Nowak, A. K., Tsao, A. S., Fujimoto, N., Peters, S., Mansfield, A. S., Popat, S., Aragon, Y. B., Talbot, T., Grossi, F., Kowalski, D., Kaplan, M. A., Cardona, A. F., Soomro, R., Hu, N., Lee, A., Ip, V., Hung, Y., Zalcman, G. (2026). Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01289